The authors reply

New England Journal of Medicine

Volumn 371, Issue 22, 2014, Pages 2140-2141

  Ryan, David P ^a   Hong, Theodore S ^a   Bardeesy, Nabeel ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INCIDENCE; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LETTER; LUNG CANCER; OVERALL SURVIVAL; PANCREAS CANCER; PATIENT REFERRAL; PROTOCOL COMPLIANCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); ADENOCARCINOMA; PANCREAS TUMOR;

ADENOCARCINOMA; HUMANS; PANCREATIC NEOPLASMS;

EID: 84915813644     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1412266     Document Type: Article

References (3)

1. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363:733-42.
2. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
3. Tanaka M, Fernández-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology 2012;12:183-97.